Trial intelligence / Profile preview

Ferinject in acute isovolemic anemia after gastrectomy

NCT01725789Phase 3Completed

Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start
Nov 2012
Primary completion
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ferric carboxymaltose in anemia, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Nov 2012; status: completed.

02

Drugs

ferric carboxymaltose
03

Conditions

anemia

Beyond the preview

Go deeper on NCT01725789.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01725789.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call